Perspective Therapeutics, Inc.
CATX
AMEX·Healthcare·Medical - Devices·Mkt cap $357.0M
$3.13
▲ +0.32%
P/E
-2.54
Mkt Cap
$357.0M
52-Wk Range
$1.96–$6.16
52-Week Range
$1.96 - $6.16
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 8.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary Cesium-131 isotope technology with superior dosimetry characteristics compared to competing brachytherapy isotopes
- Established manufacturing and distribution infrastructure for radioactive medical devices
- Regulatory clearances and clinical validation across multiple cancer indications
- Specialized sales network targeting surgical facilities and physician practices with brachytherapy capabilities
Bear Case
1 risk
- Above-average volatility (beta 1.8).
Growth
Strong growth ahead
Expansion of clinical indications and regulatory approvals for CS-1 seeds in additional cancer types
Value
Deep value opportunity - significant discount to sector peers
Momentum
Strong
+6.8% over 3m
Quality
Loss-making
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying CATX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 9, 2026
AUG 10, 2026
Reported EPS of -$0.22 vs -$0.25 consensus (+12.4% surprise). Revenue of $81.0K vs $90.5K expected (-10.5%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+12.4%
Revenue trend · last 8Q
—
-100%
—
—
—
—
-78%
-126%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$0
$0
$342.0K
$290.0K
$209.0K
$0
$76.0K
-$76.0K
Margins · last 8Q
Profit
—
Wall Street consensus
6 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: BTIG · Jul 24, 2026
vs Industry
How CATX stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.